Cycle Ergometer Training & Heart Failure on Heart Rate Recovery & Mind

Status Completed

Clinical Trial Summary

To evaluate the effects of cycle ergometer training on heart rate recovery in Newyork Heart Association (NYHA) class I and II heart patients. To evaluate the effects of cycle ergometer training on mind fullness in NYHA class I and II heart patients. Previous studies were designed to target only cardiac functions and no psychological aspect was studied so this study cover this aspect as well so from the outcomes of this study we can determine both psychological satisfaction and cardiac function as well.

Clinical Trial Description

A review stated that "clinical and experimental data shows that physical training is an important aspect in the management of chronic heart failure patients. Also, it stated that physical exercise training plays an important role to modulate peripheral immune responses if congestive heart failure (CHF) patients show high pro-inflammatory cytokines, soluble cellular adhesion molecules, which further resulted in an improvement in exercise capacity in CHF patients. Heart rate recovery (HRR) improved in patients who were enrolled in the cardiac rehabilitation stage 2 program while similar outcomes were not noted among the control group. It was concluded that cardiac rehabilitation exercise program improves heart rate recovery. Also, HRR may be used in a cardiac rehabilitation program to recognize high risk factors and also useful in evaluating the outcomes. a systematic review about the effects of exercise training in patients with CHF was published who concluded that short-term physical exercise training in selected subgroups of patients with CHF, has physiological benefits and positive effects on quality of life. A meta-analysis by the Collaborative Group concluded that there is no evidence that supervised medical training programs for patients with CHF are dangerous and indeed there is clear evidence of an overall reduction in mortality. The authors did not perform a quantitative analysis on the outcome of cardiac performance, exercise capacity, or quality of life. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04741191
Study type	Interventional
Source	Riphah International University
Contact
Status	Completed
Phase	N/A
Start date	October 1, 2020
Completion date	April 1, 2021

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04452149` - Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure	N/A
Withdrawn	`NCT03005184` - Mechanism(s) Underlying Cardiovascular Effects of ARB/NEP Inhibition - Aim 2	Phase 2
Not yet recruiting	`NCT01669395` - Severe Heart Failure and Homebased Rehabilitation - An Intersectoral Randomized Controlled Trial	N/A
Completed	`NCT05835063` - A Study to Improve Physician-Youth Communication and Medical Decision Making	N/A
Completed	`NCT03895073` - HEart fAiluRe evaluaTion Questionnaire
Completed	`NCT03095196` - Multipolar CRT-d and Diabetes	N/A
Recruiting	`NCT03180320` - Baduanjin-eight-silken-movement With Self-efficacy Building for Patients With Chronic Heart Failure (BESMILE-HF Study)	N/A
Completed	`NCT06233695` - Gender-based Differences in the Outcome of Treatment With Aldosterone Antagonists in Patients With Heart Failure
Withdrawn	`NCT03947853` - Clinical Study to Evaluate the Predictive Value of the Heart Failure Questionnaire (HF-Q) for the Occurrence of Μajor Αdverse Cardiovascular Events (MACE) in Patients With Symptomatic Heart Failure
Recruiting	`NCT05934487` - PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III	N/A
Recruiting	`NCT04829617` - Promoting Well-being and Health in Heart Failure	N/A
Recruiting	`NCT05487365` - Implementation and Cost-evaluation of a Smartphone-based Telemonitoring and Digital Support in Patients With HF	N/A
Completed	`NCT01560871` - Effects of a Walking Program and Inspiratory Muscle Training in Individuals With Chronic Heart Failure	N/A
Completed	`NCT03387813` - Hemodynamic-GUIDEd Management of Heart Failure	N/A
Enrolling by invitation	`NCT05885607` - Early Metabolic Adaptations to SGLT2 Inhibition in Heart Failure
Completed	`NCT06394986` - Cardio-fistular Recirculation in Patients With Chronic Heart Failure and Preserved Left Ventricle Ejection Fraction
Terminated	`NCT04971993` - Step and Walking Pattern From Cardiac Monitor Study
Completed	`NCT04180696` - Mid-Q Response Study	N/A
Not yet recruiting	`NCT05702970` - Beneficial Effects of Vitamin D Combined With Oral Iron Supplementation in Patients With Chronic Heart Failure and Iron Deficiency	Phase 4
Completed	`NCT04218435` - Impact of Sacubitril/Valsartan on Quality of Life and Mortality of CKD vs Non-CKD in Heart Failure Patients

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Cycle Ergometer Training and Heart Failure on Heart Rate Recovery and Mind Fullness

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms